Clinical Trial Update: Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the efficacy and safety of sorafenib in advanced renal cell carcinoma, reporting results from this setting. The update highlights the d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Mahidol University | Conditions: Renal Cell Carcinoma | Phase 3 | Status: COMPLETED